Quintiles Transnational Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.02.19	IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry (Businesswire)
31.01.19	IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial Communications (Businesswire)
30.01.19	IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019 (Businesswire)
29.01.19	IQVIA Institute for Human Data Science Study: Global Medicine Spending Exceeds $1.5 Trillion by 2023 as Spending Growth Steadies (Businesswire)
22.01.19	IQVIA Named to FORTUNE’s 2019 List of "World’s Most Admired Companies” (Businesswire)
08.01.19	IQVIA Announces Comprehensive Multi-Tenant SaaS Safety Platform for Life Sciences Industry (Businesswire)
07.01.19	IQVIA’s Orchestrated Customer Engagement (OCE) Solution Adopted by More than 30 Life Sciences Companies in First Year of Launch (Businesswire)
06.12.18	IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards (Businesswire)
30.11.18	IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
29.11.18	IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
29.11.18	IQVIA’s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency (Businesswire)
27.11.18	IQVIA’s Orchestrated Customer Engagement Selected by Novo Nordisk International Operations (Businesswire)
20.11.18	Adhera Therapeutics Selects IQVIA’s OCE Technology Platform to Support Commercial Excellence (Businesswire)
15.11.18	IQVIA Launches Digital ICF Author, a SaaS eConsent Tool to Transform the Informed Consent Process (Businesswire)
06.11.18	IQVIA to Present at the Credit Suisse Annual Healthcare Conference on November 13, 2018 (Businesswire)
22.10.18	IQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance (Businesswire)
16.10.18	IQVIA’s Commercial Technology Suite for Global Deployment Selected by Roche (Businesswire)
15.10.18	IQVIA to Announce Third-Quarter 2018 Results on October 22, 2018 (Businesswire)
04.10.18	IQVIA and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data (Businesswire)
20.09.18	IQVIA to Build Clinically-Focused Tech Solutions Suite for Life Sciences on Salesforce Health Cloud (Businesswire)
16.08.18	Theramex Chooses IQVIA’s Orchestrated Customer Engagement (Businesswire)
02.08.18	Medytox Selects IQVIA’s Enterprise Quality Management Platform, Including SmartSolve®, for Quality and Compliance Management (Businesswire)
01.08.18	IQVIA’s Jon Resnick Honored on 2018 PharmaVOICE 100 List (Businesswire)
10.07.18	IQVIA to Announce Second-Quarter 2018 Results on July 24, 2018 (Businesswire)
21.06.18	IQVIA Launches a Transformative Suite of Virtual Research Solutions (Businesswire)
13.06.18	IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
12.06.18	IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
12.06.18	IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness (Businesswire)
05.06.18	IQVIA Launches Commercial Content Management Solution IQVIA™ ePromo (Businesswire)
24.05.18	IQVIA™ Institute for Human Data Science Study: Spending on Cancer Meds in the U.S. Doubled from 2012-2017 – Expected to Double Again by 2022 to $100 Billion (Businesswire)
18.05.18	PruGen Pharmaceuticals Selects IQVIA’s OCE Technology Platform to Advance Field Sales and Home Office Effectiveness (Businesswire)
18.05.18	IQVIA Reaffirms Its Second-Quarter and Full-Year 2018 Guidance, Including Adjusted EPS Growth of 13.6% to 20.4% and 14.3% to 19.9%, Respectively (Businesswire)
18.05.18	IQVIA Holdings Inc. Provides Update on Secondary Offering (Businesswire)
16.05.18	IQVIA Response to FDA Statement (Businesswire)
16.05.18	IQVIA Announces Pricing of Secondary Public Offering (Businesswire)
15.05.18	IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock (Businesswire)
08.05.18	IQVIA to Present at the Bank of America Merrill Lynch Health Care Conference on May 15, 2018 (Businesswire)
02.05.18	IQVIA Reports First-Quarter 2018 Results and Raises Full-Year 2018 Revenue Guidance (Businesswire)
30.04.18	Recordati Selects IQVIA’s OCE Technology Platform and OneKey Information Services (Businesswire)
24.04.18	Kiwi Energy Sponsors Transportation Alternatives Bike Month (PR Newswire)
19.04.18	IQVIA™ Institute for Human Data Science Study: U.S. Prescription Opioid Volume Declined 12 Percent in 2017 – Largest Drop in 25 Years (Businesswire)
18.04.18	IQVIA to Announce First-Quarter 2018 Results on May 2, 2018 (Businesswire)
15.03.18	IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies (Businesswire)
14.03.18	IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries (Businesswire)
13.03.18	IQVIA Institute for Human Data Science Study: 10 Predictions for Innovation, Spending Drivers and Societal Value of Medicines that Will Transform Global Healthcare in 2018 and Beyond (Businesswire)
14.02.18	IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance (Businesswire)
06.02.18	IQVIA to Lead Group to Expand Safety/Efficacy Monitoring of Regulated Vaccines and Biologics for the FDA Center for Biologics Evaluation and Research (Businesswire)
19.01.18	IQVIA Named to FORTUNE’s 2018 List of "World’s Most Admired Companies” (Businesswire)
12.12.17	IQVIA and Pierre Fabre Pharmaceuticals Expand Relationship to Deploy IQVIA’s Orchestrated Customer Engagement (Businesswire)
12.12.17	IQVIA Launches Orchestrated Customer Engagement (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Quintiles Transnational Holdings INC

Aktien Top/Flop

Meistgelesene Nachrichten